EZICON Group and LISUN BIO-MEDICAL TECHNOLOGY jointly launched the innovative blood sugar management product “Phenylocyanine” in the Greater China market
EZICON Group and Taiwan’s cutting-edge biotech company, LISUN BIO-MEDICAL TECHNOLOGY, have teamed up to introduce the innovative blood sugar management product “Phenylocyanine” to the Greater China market through a cross-border e-commerce platform. As of 2024, the number of diabetes patients in China has exceeded 118 million, accounting for 22% of the total number of diabetes patients in the world. China is one of the countries with the heaviest diabetes burden in the world. In particular, it provides an innovative solution that combines the concepts of “natural plant extract technology” and “precise blood sugar regulation” to address the problem of blood sugar fluctuations caused by the fast pace of life and unstable diet of modern people.
【Phenol polycyanine】｜© LISUN BIO-MEDICAL TECHNOLOGY
Natural Plant Extracts x Scientific Evidence
Phenolic acid stabilizer is specially designed for the blood sugar fluctuations of modern people under high pressure and high sugar diet environment, combining five core ingredients of natural plant extracts:
*Guava extract: natural polyphenols that slow down carbon water absorption and stabilize blood sugar.
*Bitter melon extract: known as plant insulin, enhances metabolism.
*Wolfberry extract: strengthens immunity, regulates sugar metabolism, and reduces oxidative stress.
*Licorice extract: multiple antioxidants, stabilizes blood sugar fluctuations.
*Green tea extract: Catechins help control sugar absorption and activate metabolism.
Cross-border e-commerce layout to create a smart health ecosystem
EZICON Group will combine cross-border OMO shopping malls, self-media shopping guides and big data advertising precision push to assist Phenolpolycyantolide to quickly expand into the Chinese and Asian markets. This cooperation not only demonstrates Taiwan’s biotech research and development capabilities, but also marks an important milestone for EZICON Group in its cross-border layout of health technology. ——Said Shawn Chen, CEO of EZICON Group.
About LISUN BIO-MEDICAL TECHNOLOGY
LISUN BIO-MEDICAL TECHNOLOGY Group is a biomedical team composed of the country’s top doctors, pharmacists, and biomedical-related R&D talents. We focus on developing functional health-preserving foods with non-pharmaceutical ingredients, foods, health-preserving medicine, medical cosmetology, and preventive medicine, hoping to effectively improve the health quality and life color of modern people.
About EZICON Group – EZICON Healthcare International Co., Ltd.
EZICON Group is a global leader in cross-border e-commerce solutions, focusing on brand internationalization and market expansion, helping companies quickly enter new markets and improve their competitiveness. EZICON Group has 12 branches in the United States, Hong Kong, Singapore, Malaysia, Taiwan and China. The Group pioneered AI-based personalized health selection and precision health promotion services, combined with cross-border e-commerce to create a global precision health cross-border retail solution. Through OMO malls, micro malls, mini programs, etc., we integrate new retail systems such as social media, self-media, and live streaming to provide legal and sustainable cross-border market solutions, allowing consumers to enjoy globally selected, precise health services and products, and achieve a healthy and prosperous life.
Consult now for the most suitable pharmaceutical cross-border e-commerce solution for you
